AR050148A1 - Implante y metodo para aumentar y mejorar tejidos - Google Patents

Implante y metodo para aumentar y mejorar tejidos

Info

Publication number
AR050148A1
AR050148A1 ARP050101565A ARP050101565A AR050148A1 AR 050148 A1 AR050148 A1 AR 050148A1 AR P050101565 A ARP050101565 A AR P050101565A AR P050101565 A ARP050101565 A AR P050101565A AR 050148 A1 AR050148 A1 AR 050148A1
Authority
AR
Argentina
Prior art keywords
tissue
human
dextran microparticles
crystallized dextran
composition
Prior art date
Application number
ARP050101565A
Other languages
English (en)
Original Assignee
Technology Dev Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technology Dev Company Ltd filed Critical Technology Dev Company Ltd
Publication of AR050148A1 publication Critical patent/AR050148A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/02—Dextran; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Una composicion apropiada para aumentar y mejorar tejidos humanos que incluye micropartículas de dextrano cristalizada. Reivindicacion 1: Una composicion caracterizada porque comprende micropartículas de dextrano cristalizadas porosas, donde la composicion está envasada para el mejoramiento de tejidos. Reivindicacion 11: Un ôkitö adaptado para el mejoramiento de tejido humano, caracterizado porque comprende: micropartículas de dextrano cristalizadas; y un primer medio para administrar las micropartículas de dextrano cristalizadas en el tejido humano para mejorar el tejido. Reivindicacion 26: Un método para el mejoramiento de tejidos humanos, caracterizado porque comprende introducir una composicion que comprende micropartículas de dextrano cristalizadas en el tejido humano para mejorar el tejido humano. Reivindicacion 52: Un método para aumentar un volumen de tejido blando humano caracterizado porque comprende suministrar una cantidad efectiva de una composicion de relleno de tejido blando que comprende micropartículas de dextrano cristalizadas en el tejido blando humano para aumentar el volumen del tejido blando.
ARP050101565A 2004-04-20 2005-04-20 Implante y metodo para aumentar y mejorar tejidos AR050148A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56347404P 2004-04-20 2004-04-20

Publications (1)

Publication Number Publication Date
AR050148A1 true AR050148A1 (es) 2006-10-04

Family

ID=34980078

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101565A AR050148A1 (es) 2004-04-20 2005-04-20 Implante y metodo para aumentar y mejorar tejidos

Country Status (8)

Country Link
US (1) US20070003503A1 (es)
EP (1) EP1744728A1 (es)
KR (1) KR20070033976A (es)
CN (1) CN101035513A (es)
AR (1) AR050148A1 (es)
AU (1) AU2005235168A1 (es)
TW (1) TW200603843A (es)
WO (1) WO2005102285A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9080146B2 (en) * 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US20080226723A1 (en) * 2002-07-05 2008-09-18 Celonova Biosciences, Inc. Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same
US9107850B2 (en) * 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
ATE503465T1 (de) 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh Beladbare polyphosphazenhaltige teilchen für therapeutische und/oder diagnostische anwendungen sowie herstellungs- und verwendungsverfahren dafür
US20080274195A1 (en) 2005-07-18 2008-11-06 University Of Massachusetts Lowell Compositions and Methods for Making and Using Nanoemulsions
PL3295955T3 (pl) 2005-12-01 2021-10-25 University Of Massachusetts Lowell Nanoemulsje botulinowe
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
SE529040C2 (sv) 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
AU2007353340A1 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
JP2010528981A (ja) 2006-12-01 2010-08-26 アンテリオス， インコーポレイテッド 両親媒性実体ナノ粒子
CA2688415C (en) 2007-05-31 2015-11-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US20090110738A1 (en) * 2007-10-26 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same
US20090111763A1 (en) * 2007-10-26 2009-04-30 Celonova Biosciences, Inc. Loadable polymeric particles for bone augmentation and methods of preparing and using the same
US20090110731A1 (en) * 2007-10-30 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same
US20090110730A1 (en) * 2007-10-30 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same
CN110198703A (zh) 2016-11-21 2019-09-03 艾里奥治疗公司 大试剂的透皮递送
GB201714590D0 (en) 2017-09-11 2017-10-25 Pilkington Automotive Finland Oy Glazing with electrically operable light source

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
US5183462A (en) * 1990-08-21 1993-02-02 Associated Synapse Biologics Controlled administration of chemodenervating pharmaceuticals
US5211644A (en) * 1991-09-20 1993-05-18 Pmt Corporation Process and apparatus for a dermal graft
US6537574B1 (en) * 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
CA2379909C (en) * 1999-08-06 2011-01-04 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US20030211166A1 (en) * 2001-07-31 2003-11-13 Yamamoto Ronald K Microparticulate biomaterial composition for medical use
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
EP1184032A1 (en) * 2000-08-31 2002-03-06 OctoPlus B.V. Dextran hydrogels
AU2002315505B2 (en) * 2001-06-29 2008-01-17 Medgraft Microtech, Inc. Biodegradable injectable implants and related methods of manufacture and use
US20030068297A1 (en) * 2001-08-18 2003-04-10 Deepak Jain Composition and methods for skin rejuvenation and repair
US20110097385A1 (en) * 2003-03-04 2011-04-28 Ttdc Bio L.P. Delivery System for Drug and Cell Therapy

Also Published As

Publication number Publication date
EP1744728A1 (en) 2007-01-24
KR20070033976A (ko) 2007-03-27
TW200603843A (en) 2006-02-01
AU2005235168A1 (en) 2005-11-03
US20070003503A1 (en) 2007-01-04
WO2005102285A1 (en) 2005-11-03
CN101035513A (zh) 2007-09-12

Similar Documents

Publication Publication Date Title
AR050148A1 (es) Implante y metodo para aumentar y mejorar tejidos
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
NZ606825A (en) Methods and compositions for treating complement-associated disorders
TW200612987A (en) Combination treatment for non-hematologic malignancies
MXPA06014196A (es) Metodos y aparatos para la conservacion osea.
EP1642601A3 (en) Suture anchor and void filler combination
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
BR112014015268A2 (pt) dispositivo dental implantável e método para implantar na boca de um paciente
TW200640433A (en) Three-dimensional implantable bone support
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
UY28862A1 (es) Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
WO2006073889A3 (en) Sustained delivery of pdgf using self-assembling peptide nanofibers
PE20070437A1 (es) FORMULACION ACUOSA hFSH
CO5601022A2 (es) Metodos para tratar pacientes que padecen transtornos de movimiento
HK1150983A1 (en) Compositions for distraction osteogenesis
RU2009147168A (ru) Новое активное вещество для заживления и его применение
IL157841A0 (en) Activation of natural killer cells by adenosine a3 receptor agonists
AR037556A1 (es) Composicion farmaceutica que comprende un abridor del canal de c1c-2
EA200701599A1 (ru) Способ и композиция для восстановления сердечной ткани
SE0401182D0 (sv) Novel use of a viscoelastic composition
ZA202209988B (en) In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
AR043918A1 (es) Reduccion del crecimiento del vello utilizando una composicion que contiene difluorometilornitina
BRPI0407178A (pt) Composição farmacêutica osteogênica
AR034975A1 (es) Metodo para el tratamiento del insomnio primario

Legal Events

Date Code Title Description
FB Suspension of granting procedure